Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

When you or your bed partner has sleep apnea, a restful night’s sleep can be hard to come by. Treating this common condition ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Opens in a new tab or window The FDA recently approved the first drug specifically for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity: tirzepatide (Zepbound).

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Sleep-deprived night shift nurses are at greater risk for the common cold and other infectious diseases, a new study says.